Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
The survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors — Julia Lai‐Kwon (2018) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors
Shared by
Shahneen Sandhu
University of Melbourne
The survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors
Article
2018
en
Authors
+7 more
JL
Julia Lai‐Kwon
CK
Christine Khoo
SL
Serigne Lo
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2019
The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors
Julia Lai‐Kwon
,
Chloe Khoo
,
Serigne Lo
,
Donna Milne
,
Mustafa Abdi Mohamed
,
Jeanette Raleigh
,
Kortnye Smith
,
Karolina Lisy
,
Shahneen Sandhu
,
Michael Jefford
Article
2018
Survivorship experience for patients (pts) with metastatic melanoma (MM) on long-term targeted therapy (TT).
Chloe Khoo
,
Julia Elizabeth Lai-Kwon
,
Serigne Lo
,
Donna Milne
,
Mustafa Abdi Mohamed
,
Jeanette Raleigh
,
Kortnye Smith
,
Michael Jefford
,
Shahneen Sandhu
Article
2018
Survivorship experience for patients (pts) with metastatic melanoma (MM) on immunotherapy (IT).
Julia Elizabeth Lai-Kwon
,
Chloe Khoo
,
Serigne Lo
,
Donna Milne
,
Mustafa Abdi Mohamed
,
Jeanette Raleigh
,
Kortnye Smith
,
Shahneen Sandhu
,
Michael Jefford
Article
2017
Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
Tuba N. Gide
,
James S. Wilmott
,
Richard A Scolyer
,
Georgina V. Long
Preprint
2023
Data from Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
Tuba N. Gide
,
James S. Wilmott
,
Richard A Scolyer
,
Georgina V. Long
Discussion(0)
No comments yet. Be the first to comment.